2015
DOI: 10.1016/j.bbmt.2014.12.017
|View full text |Cite
|
Sign up to set email alerts
|

Effect of Cord Blood Processing on Transplantation Outcomes after Single Myeloablative Umbilical Cord Blood Transplantation

Abstract: Variations in cord blood manufacturing and administration are common, and the optimal practice, not known. We compared processing and banking practices at 16 public cord blood banks (CBB) in the United States, and assessed transplant outcomes on 530 single umbilical cord blood (UCB) myeloablative transplantations for hematologic malignancies, facilitated by these banks. UCB banking practices were separated into three mutually exclusive groups based on whether processing was automated or manual; units were plas… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
11
1

Year Published

2017
2017
2023
2023

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 18 publications
(13 citation statements)
references
References 25 publications
1
11
1
Order By: Relevance
“…To summarize, The results of outcome of the patients in the first MaxCell series [18] appear to be at least comparable to those reported in the medical literature [19,[23][24][25][26][27][28][29][30][31][32][33][34] and in some instances, superior to those reported for RCR CB products [18,[35][36][37][38][39][40][41][42][43][50][51][52][53][54][55][56][57][58][59]. Though, there are no published data indicating inferior outcomes with transplantation using MaxCell units [8,[35][36][37][38][39][40][41][42][43][50][51][52][53]…”
Section: Resultssupporting
confidence: 59%
See 2 more Smart Citations
“…To summarize, The results of outcome of the patients in the first MaxCell series [18] appear to be at least comparable to those reported in the medical literature [19,[23][24][25][26][27][28][29][30][31][32][33][34] and in some instances, superior to those reported for RCR CB products [18,[35][36][37][38][39][40][41][42][43][50][51][52][53][54][55][56][57][58][59]. Though, there are no published data indicating inferior outcomes with transplantation using MaxCell units [8,[35][36][37][38][39][40][41][42][43][50][51][52][53]…”
Section: Resultssupporting
confidence: 59%
“…In fact, in clinical studies of MaxCell CB products, outstanding clinical outcome in terms of engraftment and patient survival have been achieved. Table 4 showed published engraftment and survival outcome for transplantation using 1st Gen RCR CB products from diverse CB banks (NYBC, EuroCord, COBLT CBB, London CBB, French CBB) or large outcome data registries, such as CIBMTR or NMDP [19,[23][24][25][26][27][28][29][30][31][32][33][34] versus 2nd/3rd Gen Max Cell CB products [8].…”
Section: St Generation Rcr 2nd/3rd Generation Maxcellmentioning
confidence: 99%
See 1 more Smart Citation
“…The clinical outcomes of transplantation are influenced by the number of TNCs and CD34+ cells, and by HLA (human leukocyte antigen) matching [ 29 , 30 , 31 ]. However, the reduced CB volume post-processing has not been observed to affect transplantation outcomes [ 32 , 33 ]. Cryopreservation for future use and establishment of insurance reimbursement have met the increasing demand for precision health care.…”
Section: Discussionmentioning
confidence: 99%
“…For cord blood, clinical outcomes of transplants are influenced by the graft characteristics, including nucleated cell dose, stem cell dose, and HLA match, while the impact of the volume reduction processing technology used in preparing cord blood for cryopreservation is less evident, assuming that units selected meet appropriate criteria for the individual recipient and appropriate methods for thawing are followed [36,37]. While cryopreservation of umbilical cord tissue and placenta as source material have been an integral part of stimulating new avenues of clinical research, their rapid adoption led to a variety of different approaches for preparation and cryopreservation.…”
Section: Emerging Advanced Cellular Therapies and Changes To The Bmentioning
confidence: 99%